Rheumatoid Arthritis Active Not Recruiting Phase 4 Trials for Abatacept (DB01281)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02353780Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or AbataceptBasic Science
NCT01557374TOward the Lowest Effective DOse of Abatacept or TocilizumabTreatment
NCT01491815Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionTreatment
NCT02557100Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid ArthritisBasic Science
NCT01758198Abatacept Post-marketing Clinical Study in JapanTreatment